Evidence map›Paper›PMID 37588003›Full record

ArticleFrontiers in medicine2023

Comparative study of

Xiongjian Hu, Yiming Cao, Bin Ji, Min Zhao, Qiang Wen, Bin Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiongjian HuDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Yiming CaoDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Bin JiDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Min ZhaoDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Qiang WenDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Bin ChenDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
Jilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to compare the diagnostic efficiency of Methods: A retrospective analysis was conducted on 31 patients with confirmed prostate cancer between September 2020 and September 2022 at China-Japan Union Hospital of Jilin University. All patients underwent Results: Of the 31 prostate cancer patients, 18 were diagnosed with bone metastases, with a total of 84 bone metastatic lesions. At the patient level, Conclusion: Compared with

Indexed as

18F-DCFPyLbone metastasisbone scanprostate cancerprostate-specific membrane antigen

Identifiers

PMID37588003
PMCPMC10425766
OpenAlexW4385411047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.